Tauriga Sciences Inc (TAUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2013 | 12-2012 | 03-2012 | 03-2011 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 610 | 9 | 50 |
| Receivables | N/A | 0 | 0 | 0 | 4 |
| Other current assets | 0 | 0 | 20 | 0 | -4 |
| TOTAL | $N/A | $0 | $630 | $9 | $50 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 40 | 8 | N/A |
| TOTAL | $N/A | $N/A | $40 | $8 | $N/A |
| Total Assets | $N/A | $0 | $660 | $10 | $60 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 570 | 130 |
| Accounts payable and accrued liabilities | 0 | 0 | 200 | 190 | 130 |
| Accrued Expenses | N/A | 0 | 240 | 380 | 30 |
| Other current liabilities | N/A | 0 | 100 | 330 | 260 |
| TOTAL | $N/A | $0 | $730 | $1,660 | $730 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | 0 | 140 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $140 |
| Total Liabilities | $N/A | $0 | $730 | $1,660 | $880 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 0 | 1 | 1 | 0 |
| Retained earnings | N/A | 0 | -20,830 | -14,590 | -11,780 |
| Other shareholders' equity | 0 | 0 | -1 | -21 | -20 |
| TOTAL | $N/A | $0 | $-60 | $-1,640 | $-820 |
| Total Liabilities And Equity | $0 | $0 | $670 | $20 | $60 |